- June 2023Marina Pacific: A Rare Glimpse into a Pandemic-Related Property Coverage Trial
- June 9, 2023Astellas Pharma Inc. v. Sandoz Inc.
- May 2023Raoul Shah: Keeping Humanity and Compassion Close
- Janssen Pharms., Inc. v. Mylan Labs. Ltd.
- 2023 Bulletin - First QuarterGENERICally Speaking: A Hatch-Waxman Litigation Bulletin 2023 Q1
- In re Sugammadex
- Vanda Pharms. Inc. v. Teva Pharms. USA, Inc.
- Azurity Pharms., Inc. v. Alkem Labs. Ltd.
- Bristol-Myers Squibb Co. v. Xspray Pharma AB
- Drafting Subsequent Agreements to Avoid Arbitrability Litigation
- Amgen Inc. v. Sandoz Inc.
- March 2023Achieving the Largest Jury Verdict in Minnesota History
- UCB, Inc. v. Actavis Labs. UT, Inc.
- First QuarterANDA Approvals
- First QuarterANDA Litigation Settlements
- Purdue Pharma L.P. v. Accord Healthcare Inc.
- First QuarterGeneric Launches
- First QuarterNew ANDA Cases
- Bristol-Myers Squibb Co. v. Nanocopoeia, LLC
- March 2023Unintended Consequences of Banning Noncompete Agreements
- What I’ll Be Watching for in the Amgen Oral Arguments
- March 2023Should you take financial advice from Magnum P.I.?
- March 2023When Lending a Hand Results in Liability
- March 2023How an Investor Can Lose More Than Just Their Investment
- March 2023When Lending a Hand Results in Liability
- March 2023Should you take financial advice from Magnum P.I.?
- Feb. 24, 2023Jazz Pharms., Inc. v. Avadel CNS Pharms.
- A World Without Noncompetes: Protecting Confidential Information and Trade Secrets
- February 7, 2023When Monkey Business Slips Into Trademark Infringement
- Feb. 10, 2023Azurity Pharms., Inc. v. Alkem Labs. Ltd.
- Feb. 10, 2023Vanda Pharms. Inc. v. Teva Pharms. USA, Inc.
- Fourth QuarterANDA Approvals
- Briefly: Column to Continue With New Authors at Helm
- Jan. 19, 2023Exelixis, Inc. v. MSN Labs. Private Ltd.
- Jan. 6, 2023Azurity Pharms., Inc. v. Bionpharma Inc.
- January 2023Robins Kaplan Pursuing Camp Lejeune Claims
- January 2023Rayna Kessler Appointed Liaison Counsel in Exactech Multi-District Litigation
- January 2023Greta Wiessner: Making the Civil Rights Movement a Modern-Day Reality
- December 30, 2022Astellas US LLC v. Hospira, Inc.
- Takeda Pharm. Co. Ltd. v. Norwich Pharms., Inc.
- December 2022Voluntary Cessation Doctrine in Trademark Cases
- Genentech, Inc. v. Sandoz Inc.
- December 21, 2022Arius Two, Inc. v. Alvogen PB Rsch. & Dev. LLC
- December 2022The Note From the Deliberating Jury
- December 2022Chambers v. Gold Medal Bakery: An Illustration of Privilege in Shareholder Suits
- December 2022Wearing the Right Hat
- Vanda Pharms., Inc. v. Teva Pharms. USA, Inc.
- Ferring Pharms. Inc. v. Fresenius Kabi USA, LLC
- December 8, 2022Lessons From MMAS Research About Dispositive Pitfalls in Copyright Litigation
- December 7, 2022Briefly: Electing Justice: How to Judge Judges
